| Insider | Moreadith Randall |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Mar 19, 2026 |
| Expiration Date | May 6, 2031 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 20, 2026 |
| Shares Purchased | 39,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 274,186 |
| Derivative | Derivative |
| Accession Number | 0001301120-26-000016 |
| Document | View SEC Filing |